Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Search Results to

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of A phase II trial of imatinib mesylate in patients with metastatic pancreatic cancer.

PropertyValue
has major subject area list Antineoplastic Agents; Pancreatic Neoplasms; Piperazines; Pyrimidines
information resource reference Gharibo M, Patrick-Miller L, Zheng L, Guensch L, Juvidian P, Poplin E. A phase II trial of imatinib mesylate in patients with metastatic pancreatic cancer. Pancreas. 2008 May; 36(4):341-5.
label A phase II trial of imatinib mesylate in patients with metastatic pancreatic cancer.

Search Criteria
  • Pancreatic Neoplasms